BIB · ProShares Ultra Nasdaq Biotechnology 2X Shares
United States · RS rating 90 · As of 2026-10-14
| Price | 106.82 USD |
|---|---|
| 1-day change | +3.1% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 56 / 83 / 92 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 50 / 25 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +15.4% |
| Market cap (USD) | – |